Why did Agilent acquire Stratagene?
Stratagene’s development and manufacturing capabilities for specialized life science research and diagnostic products strengthen Agilent’s role as a Life Sciences company and support our commitment to help customers get better results, faster than ever. Additionally, the acquisition offers Agilent an entry into a broader customer base, and the ability to offer our customers more complete solutions for their workflow requirements. The Hycor diagnostic unit offers Agilent a urinalysis and immunology product portfolio in the growing allergy and autoimmune markets. Hycor operations are ISO 13485 certified and GMP compliant and can serve as manufacturing sites for emergent Agilent diagnostic products.